SPRB

Spruce Biosciences Inc.

Price

$46.61

return (12m)

34,425.93% Logo

p/e

-1.14

p/bv

1.22

DIVIDEND YIELD

0.00%

SPRB price

Spruce Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SPRB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.97%

3 months

-17.61%

1 year

34,425.93%

2 years

32.74%

5 years

-92.66%

10 years

0.00%

Fundamentals SPRB

Valuation

P/E

-1.14

Sector -3.98

Industry -3.98

P/BV

1.22

Sector 2.00

Industry 2.00

P/Revenue (PSR)

Sector -4.41

Industry -4.41

EV/EBITDA

0.56

Sector -245.01

Industry -245.01

EV/EBIT

0.55

Sector -666.51

Industry -666.51

P/EBITDA

-1.17

Sector -4.07

Industry -4.07

P/EBIT

-1.16

Sector -4.24

Industry -4.24

P/Total Assets

0.75

Sector 1.40

Industry 1.40

P/Net Current Assets

1.26

Sector -11.65

Industry -11.65

P/Working Capital

0.98

Sector -10.95

Industry -10.95

EPS

-37.20

Sector -2.20

Industry -2.20

BVPS

34.65

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.05%

Industry 36.05%

EBITDA Margin

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

0.00%

Sector -38.74%

Industry -38.74%

Net Profit Margins

0.00%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-107.36%

Sector -66.41%

Industry -66.41%

ROA

-66.23%

Sector -66.55%

Industry -66.55%

ROIC

-1,572.07%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.67

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.29

Sector -14.63

Industry -14.63

Net Debt / EBIT

4.19

Sector -7.24

Industry -7.24

Net Debt / Equity

-1.40

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

0.16

Sector -0.02

Industry -0.02

Equity/Assets

0.62

Sector 0.42

Industry 0.42

Liabilities/Assets

0.38

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-2.53%

Sector -

Industry -

Fundamentals SPRB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
SPRB	-1.14	1.22	-107.36%	0.00%	$42.26 M	0.00%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SPRB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Spruce Biosciences

Spruce Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

17

Employees

Spruce Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $42.26 million, with shareholders equity totaling $34.65 million.

The company employs approximately 17 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Spruce Biosciences Inc. reported $- in revenue, generating net income of $-37.20 million.

Key financial metrics include a P/E ratio of -1.14, a price-to-book (P/B) ratio of 1.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SPRB.

Market cap

$42.26 million

Net worth

$34.65 million

$34,650,000.00

Assets

$56.17 million

$56,170,000.00

Total Shares Outstanding

1.00 million

1,000,000

Average Daily Trading Volume

$69.06 Thousand

$69,057.64

Sector

Health Care

Industry

Biotechnology

SPRB

SPRB revenue and profits

Financial Results SPRB

DRAG THE FRAME TO SEE MORE DATA

SPRB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$877.23 25,29% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$239.23 54,37% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$257.59 55,58% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$246.20 30,54% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$128.33 67,99% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$161.50 10,88% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$44.53 --4,26% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$877.23 25,29% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$239.23 54,37% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$257.59 55,58% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$246.20 30,54% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$128.33 67,99% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$161.50 10,88% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$44.53 --4,26% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Spruce Biosciences (SPRB) today?

A cotação de Spruce Biosciences (SPRB) hoje está em US$ 46.61, com uma variação de 34425.93% em relação ao último ano. A cotação de Spruce Biosciences (SPRB) iniciou o ano negociando na casa dos US$ 87.11 e hoje está em US$ 46.61. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Spruce Biosciences (SPRB) e dados de ações do Ibovespa e mercados internacionais.

Quando Spruce Biosciences (SPRB) paga dividendos?

Spruce Biosciences (SPRB) não distribuiu dividendos no último ano.

Is Spruce Biosciences (SPRB) a good investment?

Atualmente, Spruce Biosciences (SPRB) está cotada a US$ 46.61, com um P/L de -1.14, representando um desvio de -169% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 34425.93 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 34,425.93%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Spruce Biosciences (SPRB) stock?

Investir em ações de Spruce Biosciences (SPRB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Spruce Biosciences (SPRB) yield today?

A rentabilidade de Spruce Biosciences (SPRB) foi de -7.97% no último mês, 34,425.93% no último ano e -92.66% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Spruce Biosciences (SPRB) hoje, o investimento total seria de US$ 4,661.00, com base na cotação atual de US$ 46.61.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,609,253.60
Em 5 anos: US$ 342.12
Em 10 anos: US$ 4,661.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SPRB

Spruce Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SPRB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Spruce Biosciences

Spruce Biosciences Inc.

United States

10 years

2020

17

PROFIT X PRICE SPRB

Financial Results SPRB

SPRB cash flow

Asset, Revenue and Profit Growth - SPRB

SPRB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions